Cash flow Damora Therapeutics, Inc.

Equities

DMRA

US36322Q2066

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 21:00:00 05/06/2026 BST			5-day change	1st Jan Change
21.01 ^USD	-5.83%		-15.55%	-8.69%

05-28	Wedbush Initiates Damora Therapeutics at Outperform With $35 Price Target	MT
05-12	Damora Therapeutics reports first quarter 2026 financial results	RE

8133581801ad39c67ff7c2f2bd3ac.PLKwv2gdJ-MKHRt6GzknCpP0qm7UQ9o1WujwiWlChLE.ZfvX9g1-U6RkV2xJbFERedSkkhyyIJVWNYqcxhsUwOdYxMrMK3dOjn5bKw

Published financial data: DAMORA THERAPEUTICS, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Selling General & Admin Expenses, Total	13.74M	13M	12.69M	10.5M	9.68M
R&D Expenses	38.49M	48.21M	23.77M	6.4M	26.88M
Other Operating Expenses, Total	52.23M	61.21M	36.46M	16.9M	36.56M
Operating Income	-52.23M	-61.21M	-36.46M	-16.9M	-36.56M
Interest Expense, Total	-	-	-	-	-
Interest And Investment Income	1.23M	1.29M	1.26M	914K	1.17M
Net Interest Expenses	1.23M	1.29M	1.26M	914K	1.17M
Currency Exchange Gains (Loss)	319K	-1.07M	-197K	18K	-84K
Other Non Operating Income (Expenses)	-	-	-	-	-
EBT, Excl. Unusual Items	-50.68M	-60.99M	-35.4M	-15.96M	-35.48M
Restructuring Charges	-	-	-3.45M	-968K	-
Gain (Loss) On Sale Of Investments	-1.07M	-636K	431K	-70K	-
Gain (Loss) On Sale Of Assets	-	-	64K	-	-
In Process R&D Expenses	-	-	-	-4.4M	-174M
EBT, Incl. Unusual Items	-51.75M	-61.62M	-38.35M	-21.4M	-210M
Income Tax Expense	-	-	-	41K	50K
Earnings From Continuing Operations	-51.75M	-61.62M	-38.35M	-21.44M	-210M
Net Income to Company	-51.75M	-61.62M	-38.35M	-21.44M	-210M
Net Income - (IS)	-51.75M	-61.62M	-38.35M	-21.44M	-210M
Preferred Dividend and Other Adjustments	-	-	-	-	-
Net Income to Common Incl Extra Items	-51.75M	-61.62M	-38.35M	-21.44M	-210M
Net Income to Common Excl. Extra Items	-51.75M	-61.62M	-38.35M	-21.44M	-210M
Per Share Items
Net EPS - Basic	-51.22	-60.63	-36.08	-18.53	-153.95
Basic EPS - Continuing Operations	-51.22	-60.63	-36.08	-18.53	-153.95
Basic Weighted Average Shares Outstanding	1.01M	1.02M	1.06M	1.16M	1.36M
Net EPS - Diluted	-51.22	-60.63	-36.08	-18.53	-153.95
Diluted EPS - Continuing Operations	-51.22	-60.63	-36.08	-18.53	-153.95
Diluted Weighted Average Shares Outstanding	1.01M	1.02M	1.06M	1.16M	1.36M
Normalized Basic EPS	-31.35	-37.5	-20.81	-8.62	-16.27
Normalized Diluted EPS	-31.35	-37.5	-20.81	-8.62	-16.27
Supplemental Items
EBITDA	-52.21M	-61.16M	-36.19M	-16.88M	-36.54M
EBITA	-52.23M	-61.21M	-36.46M	-16.9M	-36.56M
EBIT	-52.23M	-61.21M	-36.46M	-16.9M	-36.56M
EBITDAR	-51.71M	-60.66M	-35.62M	-16.65M	-36.52M
Effective Tax Rate - (Ratio)	-	-	-	-0.19	-0.02
Normalized Net Income	-31.68M	-38.12M	-22.12M	-9.98M	-22.17M
Interest on Long-Term Debt	-	-	-	-	6K
Supplemental Operating Expense Items
General and Administrative Expenses	13.74M	13M	12.69M	10.5M	9.68M
Research And Development Expense From Footnotes	39.39M	49.01M	24.57M	11.59M	202M
Net Rental Expense, Total	496K	506K	571K	224K	20K
Stock-Based Comp., R&D Exp. (Total)	1.9M	2.62M	2.45M	896K	228K
Stock-Based Comp., G&A Exp. (Total)	2.58M	2.95M	2.98M	2.34M	770K
Stock-Based Comp., Other (Total)	-	-	-	93K	39K
Total Stock-Based Compensation	4.48M	5.57M	5.43M	3.33M	1.04M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	62.56M	32.79M	21.46M	14.18M	258M
Short Term Investments	37.63M	27.44M	11.69M	-	-
Total Cash And Short Term Investments	100M	60.22M	33.15M	14.18M	258M
Other Receivables	2.28M	1.38M	1.72M	881K	899K
Total Receivables	2.28M	1.38M	1.72M	881K	899K
Prepaid Expenses	1.73M	805K	774K	590K	577K
Other Current Assets, Total	5.9M	1.5M	1.13M	1.19M	1.32M
Total Current Assets	110M	63.91M	36.77M	16.84M	260M
Gross Property Plant And Equipment	1.06M	1.23M	354K	180K	176K
Accumulated Depreciation	-20K	-62K	-29K	-50K	-72K
Net Property Plant And Equipment	1.04M	1.17M	325K	130K	104K
Long-term Investments	9.05M	5.83M	-	-	-
Other Long-Term Assets, Total	2.03M	2.28M	1.13M	163K	-
Total Assets	122M	73.19M	38.23M	17.13M	261M
Liabilities
Accounts Payable, Total	1.53M	3.35M	1.7M	377K	17.66M
Accrued Expenses, Total	2.18M	6.74M	1.67M	321K	719K
Current Portion of Leases	399K	476K	183K	12K	15K
Other Current Liabilities	438K	539K	2.27M	487K	1.67M
Total Current Liabilities	4.54M	11.11M	5.83M	1.2M	20.07M
Long-Term Leases	448K	328K	66K	61K	53K
Other Non Current Liabilities	-	-	-	43K	28K
Total Liabilities	4.99M	11.44M	5.9M	1.3M	20.15M
Preferred Stock Redeemable	-	-	-	-	-
Preferred Stock Convertible	-	-	-	1.36M	416M
Total Preferred Equity	-	-	-	1.36M	416M
Additional Paid In Capital	274M	280M	288M	292M	311M
Retained Earnings	-156M	-218M	-256M	-278M	-487M
Comprehensive Income and Other	-320K	-244K	380K	97K	802K
Total Common Equity	117M	61.75M	32.33M	14.47M	-176M
Total Equity	117M	61.75M	32.33M	15.83M	240M
Total Liabilities And Equity	122M	73.19M	38.23M	17.13M	261M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	1.01M	1.03M	1.08M	1.32M	60.3M
ECS Total Common Shares Outstanding	1.01M	1.03M	1.08M	1.32M	1.6M
Book Value / Share	116.01	60.18	29.81	10.99	-110.1
Tangible Book Value	117M	61.75M	32.33M	14.47M	-176M
Tangible Book Value Per Share	116.01	60.18	29.81	10.99	-110.1
Total Debt	847K	804K	249K	73K	68K
Net Debt	-108M	-65.25M	-32.9M	-14.1M	-258M
Debt Equivalent Oper. Leases	3.97M	4.05M	4.57M	1.79M	160K
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	223K	419K	107K	107K	108K
Full Time Employees	40	45	13	5	7

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-51.75M	-61.62M	-38.35M	-21.44M	-210M
Depreciation & Amortization - CF	441K	490K	830K	181K	34K
Depreciation & Amortization, Total	441K	490K	830K	181K	34K
(Gain) Loss From Sale Of Asset	-	-	-64K	-	-
(Gain) Loss on Sale of Investments - (CF)	1.07M	636K	-431K	70K	-
Asset Writedown & Restructuring Costs	-	-	-	-	174M
Stock-Based Compensation (CF)	4.48M	5.57M	5.43M	3.33M	1.04M
Other Operating Activities, Total	75K	58K	46K	1.9M	9.37M
Change In Accounts Payable	-1.32M	1.82M	-1.65M	-1.32M	17.27M
Change in Other Net Operating Assets	-5.3M	10.12M	-2.72M	-1.34M	1.09M
Cash from Operations	-52.31M	-42.93M	-36.91M	-18.62M	-6.73M
Capital Expenditure	-223K	-196K	-	-	-
Sale of Property, Plant, and Equipment	-	-	83K	-	-
Cash Acquisitions	-	-	-	-	-17.37M
Investment in Marketable and Equity Securities, Total	-47.82M	12.58M	22.25M	11.65M	-
Cash from Investing	-48.05M	12.38M	22.33M	11.65M	-17.37M
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	-	-	-	-
Issuance of Common Stock	-	507K	3.08M	-	33K
Issuance of Preferred Stock	-	-	-	-	267M
Other Financing Activities, Total	-	-	-200K	-	-
Cash from Financing	-	507K	2.88M	-	267M
Foreign Exchange Rate Adjustments	-917K	264K	384K	-317K	705K
Net Change in Cash	-101M	-29.78M	-11.32M	-7.29M	243M
Supplemental Items
Cash Income Tax Paid (Refund)	-	-	-	-	5K
Levered Free Cash Flow	-33.19M	-19.68M	-21.45M	-10.55M	-3.05M
Unlevered Free Cash Flow	-33.19M	-19.68M	-21.45M	-10.55M	-3.05M
Change In Net Working Capital	5.24M	-12.71M	4.92M	3.5M	-18.73M
Net Debt Issued / Repaid	-	-	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-22.22	-39.15	-40.9	-38.15	-16.46
Return on Total Capital	-22.95	-42.36	-47.9	-43.56	-17.83
Return On Equity %	-36.61	-68.86	-81.52	-89.03	-163.8
Return on Common Equity	-36.61	-68.86	-81.52	-91.62	260.02
Short Term Liquidity
Current Ratio	24.23	5.75	6.31	14.07	12.98
Quick Ratio	22.55	5.55	5.98	12.58	12.88
Operating Cash Flow to Current Liabilities	-11.51	-3.87	-6.33	-15.56	-0.34
Long Term Solvency
Total Debt/Equity	0.72	1.3	0.77	0.46	0.03
Total Debt / Total Capital	0.72	1.29	0.76	0.46	0.03
LT Debt/Equity	0.38	0.53	0.2	0.39	0.02
Long-Term Debt / Total Capital	0.38	0.52	0.2	0.38	0.02
Total Liabilities / Total Assets	4.08	15.62	15.42	7.59	7.73
EBIT / Interest Expense	-	-	-	-	-
Total Debt / EBITDA	-0.02	-0.01	-0.01	-0	-0
Net Debt / EBITDA	2.1	1.08	0.92	0.85	7.05
Total Debt / (EBITDA - Capex)	-0.02	-0.01	-0.01	-0	-0
Net Debt / (EBITDA - Capex)	2.09	1.07	0.92	0.85	7.05
Growth Over Prior Year
EBITDA, 1 Yr. Growth %	-	17.16	-40.84	-53.37	116.52
EBITA, 1 Yr. Growth %	55.27	17.19	-40.44	-53.65	116.38
EBIT, 1 Yr. Growth %	55.27	17.19	-40.44	-53.65	116.38
Earnings From Cont. Operations, 1 Yr. Growth %	48.55	19.08	-37.77	-44.1	878.77
Net Income, 1 Yr. Growth %	48.55	19.08	-37.77	-44.1	878.77
Normalized Net Income, 1 Yr. Growth %	45.48	20.34	-41.96	-54.9	122.23
Diluted EPS Before Extra, 1 Yr. Growth %	-73.11	18.39	-40.49	-48.65	730.95
Net Property, Plant and Equip., 1 Yr. Growth %	17.18	12.54	-72.15	-60	-20
Total Assets, 1 Yr. Growth %	-28.78	-40.12	-47.77	-55.18	1.42K
Tangible Book Value, 1 Yr. Growth %	-29.17	-47.32	-47.64	-55.24	-1.32K
Common Equity, 1 Yr. Growth %	-29.17	-47.32	-47.64	-55.24	-1.32K
Cash From Operations, 1 Yr. Growth %	36.92	-17.92	-14.02	-49.55	-63.88
Capital Expenditures, 1 Yr. Growth %	-	-12.11	-	-	-
Levered Free Cash Flow, 1 Yr. Growth %	-299.95	-40.71	9	-50.81	-71.1
Unlevered Free Cash Flow, 1 Yr. Growth %	-299.95	-40.71	9	-50.81	-71.1
Compound Annual Growth Rate Over Two Years
EBITDA, 2 Yr. CAGR %	-	-	-16.74	-47.47	0.49
EBITA, 2 Yr. CAGR %	53.44	34.89	-16.45	-47.46	0.14
EBIT, 2 Yr. CAGR %	53.44	34.89	-16.45	-47.46	0.14
Earnings From Cont. Operations, 2 Yr. CAGR %	19.06	33	-13.92	-41.02	133.92
Net Income, 2 Yr. CAGR %	19.06	33	-13.92	-41.02	133.92
Normalized Net Income, 2 Yr. CAGR %	60.32	32.31	-16.43	-48.84	0.12
Diluted EPS Before Extra, 2 Yr. CAGR %	-88.75	-43.58	-16.07	-44.72	106.57
Net Property, Plant and Equip., 2 Yr. CAGR %	86.54	14.83	-44.02	-66.62	-43.43
Total Assets, 2 Yr. CAGR %	46.93	-34.69	-44.07	-51.62	161.06
Tangible Book Value, 2 Yr. CAGR %	28.36	-38.91	-47.48	-51.59	133.23
Common Equity, 2 Yr. CAGR %	28.36	-38.91	-47.48	-51.59	133.23
Cash From Operations, 2 Yr. CAGR %	64.52	6.01	-16	-34.14	-57.31
Levered Free Cash Flow, 2 Yr. CAGR %	-18.06	8.88	-19.61	-26.78	-62.3
Unlevered Free Cash Flow, 2 Yr. CAGR %	-18.06	8.88	-19.61	-26.78	-62.3
Compound Annual Growth Rate Over Three Years
EBITDA, 3 Yr. CAGR %	-	-	-	-31.37	-15.78
EBITA, 3 Yr. CAGR %	59.35	40.26	2.72	-31.35	-15.78
EBIT, 3 Yr. CAGR %	59.35	40.26	2.72	-31.35	-15.78
Earnings From Cont. Operations, 3 Yr. CAGR %	48.29	19.07	3.25	-25.45	50.45
Net Income, 3 Yr. CAGR %	48.29	19.07	3.25	-25.45	50.45
Normalized Net Income, 3 Yr. CAGR %	47.26	45.7	0.53	-31.96	-16.52
Diluted EPS Before Extra, 3 Yr. CAGR %	-69.63	-75.34	-42.57	-28.75	36.43
Net Property, Plant and Equip., 3 Yr. CAGR %	-	57.62	-28.39	-49.95	-55.33
Total Assets, 3 Yr. CAGR %	51.56	8.94	-39.38	-48.05	52.69
Tangible Book Value, 3 Yr. CAGR %	51.32	-4.61	-41.97	-50.21	41.75
Common Equity, 3 Yr. CAGR %	51.32	-4.61	-41.97	-50.21	41.75
Cash From Operations, 3 Yr. CAGR %	56.33	30.48	-1.14	-29.12	-46.09
Levered Free Cash Flow, 3 Yr. CAGR %	-	-26.43	8.92	-31.75	-46.29
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-26.43	8.92	-31.75	-46.29
Compound Annual Growth Rate Over Five Years
EBITA, 5 Yr. CAGR %	-	-	23.08	-5.3	1.68
EBIT, 5 Yr. CAGR %	-	-	23.08	-5.3	1.68
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	19.3	-10.1	43.21
Net Income, 5 Yr. CAGR %	-	-	19.3	-10.1	43.21
Normalized Net Income, 5 Yr. CAGR %	-	-	17.4	-4.14	0.37
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-54.39	-65.95	-4.17
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	-15.29	-34.83
Total Assets, 5 Yr. CAGR %	-	-	1.72	-21.26	8.71
Tangible Book Value, 5 Yr. CAGR %	-	-	-0.91	-27.28	1.22
Common Equity, 5 Yr. CAGR %	-	-	-0.91	-27.28	1.22
Cash From Operations, 5 Yr. CAGR %	-	-	21.94	-0.74	-29.35
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-26.57	-28.74
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-26.57	-28.74